Abstract
Sixty-three consecutive streptococcal blood isolates from neutropenic patients, represented mainly by viridans group streptococci, were evaluated in vitro for antibiotic susceptibility. Of these isolates, 79.3% were highly susceptible to penicillin (MIC, less than or equal to 0.12 microgram/ml). Overall, imipenem was the most active agent, followed by teicoplanin and vancomycin. All other agents showed decreased activity against streptococcal isolates that were not highly susceptible to penicillin.
Full text
PDF![580](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a584/172484/31fe74056eed/aac00072-0192.png)
![581](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a584/172484/18e87271daa0/aac00072-0193.png)
![582](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a584/172484/eff5bdc62c6e/aac00072-0194.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bourgault A. M., Wilson W. R., Washington J. A., 2nd Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis. 1979 Sep;140(3):316–321. doi: 10.1093/infdis/140.3.316. [DOI] [PubMed] [Google Scholar]
- Brown A. E. Neutropenia, fever, and infection. Am J Med. 1984 Mar;76(3):421–428. doi: 10.1016/0002-9343(84)90661-2. [DOI] [PubMed] [Google Scholar]
- Cohen J., Donnelly J. P., Worsley A. M., Catovsky D., Goldman J. M., Galton D. A. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet. 1983 Dec 24;2(8365-66):1452–1454. doi: 10.1016/s0140-6736(83)90799-7. [DOI] [PubMed] [Google Scholar]
- Facklam R. R., Rhoden D. L., Smith P. B. Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. J Clin Microbiol. 1984 Nov;20(5):894–898. doi: 10.1128/jcm.20.5.894-898.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Henslee J., Bostrom B., Weisdorf D., Ramsay N., McGlave P., Kersey J. Streptococcal sepsis in bone marrow transplant patients. Lancet. 1984 Feb 18;1(8373):393–393. doi: 10.1016/s0140-6736(84)90440-9. [DOI] [PubMed] [Google Scholar]
- Kern W., Kurrle E., Vanek E. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. Klin Wochenschr. 1987 Aug 17;65(16):773–780. doi: 10.1007/BF01743253. [DOI] [PubMed] [Google Scholar]
- Menichetti F., Del Favero A., Guerciolini R., Tonato M., Frongillo R. F., Roila F., Pauluzzi S. Viridans streptococci septicemia in cancer patients: a clinical study. Eur J Epidemiol. 1987 Sep;3(3):316–318. doi: 10.1007/BF00149743. [DOI] [PubMed] [Google Scholar]
- Ognibene F. P., Martin S. E., Parker M. M., Schlesinger T., Roach P., Burch C., Shelhamer J. H., Parrillo J. E. Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med. 1986 Aug 28;315(9):547–551. doi: 10.1056/NEJM198608283150904. [DOI] [PubMed] [Google Scholar]
- Sands M., Sommers H. M., Rubin M. B. Speciation of the "viridans" streptococci. Am J Clin Pathol. 1982 Jul;78(1):78–80. doi: 10.1093/ajcp/78.1.78. [DOI] [PubMed] [Google Scholar]